Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Indulgence
Premium
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Associate Sponsors
Popular Search
Alembic Pharma gets tentative nod from USFDA for diabetes management drug
The product is therapeutically equivalent to Synjardy tablets of Boehringer Ingelheim Pharmaceuticals, Inc
FDA new drug approval run rate down in FY20 for most Indian pharma majors
According to analysts, companies are skeptical about entering crowded opportunities
Alembic Pharma rises 3% as JV firm successfully completes USFDA inspection
The inspection was carried out from January 6 to January 8.
Alembic Pharma gets USFDA nod for neuropathic pain management drug
The approved product is therapeutically equivalent to the reference listed drug Lyrica Capsules
Alembic Pharma gets USFDA nod for solution to treat allergic conjunctivitis
The company said it currently has 83 ANDA approvals from USFDA
Alembic Pharma gains 5% on successful USFDA inspection of Panelav facility
The stock was up 5% at Rs 527 on the BSE in early morning trade after the company informed that the successful USFDA inspection at its API facility at Panelav with zero 483s.
Alembic Pharma gets USFDA nod for bladder drug
The approved product is equivalent to Enablex of Allergan Pharmaceuticals
